Replies to post #2386 on Ehave, Inc. (EHVVF)

[ProfitScout]

Very good to see EHVVF gaining new attention for the company's important advancements in the emerging field of mental health and wellness.

From the Roth Capital news:

Ehave Inc (OTC:EHVVF), a leading healthcare services and technology company, announced on April 19 that its mobile application platform MetaHealthU will enter the market with a focus on determining the cause and finding a possible cure for hallucinogen-persisting perception disorder (HPPD). Ehave pioneered HPPD research efforts by initiating a series of studies through its partnership with the University of Melbourne to gather data and biomarkers to target the disease. As psychedelics become more widely accepted, Ehave's MetaHealthU data and biomarkers will help medical and mental health professionals diagnose whether an individual is genetically predisposed to suffer from HPPD. One of the components of MetaHealthU is its digital wallet connectivity with the blockchain, which allows users to aggregate and share their health records securely and seamlessly. The pilot study will begin at the end of the second trimester or the beginning of the third trimester.

Roth Capital Reveals Top Psychedelic Picks in New Industry Report https://prnewswire.com/news-releases/roth-capital-reveals-top-psychedelic-picks-in-new-industry-report-301529820.html